Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 225

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 225
---
 independent under SEC rules. Although we do not have a formal policy regarding attendance by members of our board of directors at the annual meeting of stockholders, members of our board are encouraged to attend. Three (3) of our directors attended the 2024 Annual Meeting of Stockholders. Board Committees We have established the following board committees: Audit Committee, Compensation Committee and a Nominating and Corporate Governance Committee. Each committee operates pursuant to a charter adopted by our board of directors. The composition and functioning of all committees comply with all applicable requirements of the Sarbanes-Oxley Act of 2002, SEC rules and regulations, and Nasdaq. The following table sets forth which directors currently serve on each committee of the board of directors.

| Audit                 |     | Compensation           |     | Nominating and Corporate       
 Governance                     |
| Emma Reeve (Chair)    |     | Richard Maroun (Chair) |     | Anupam Dalal, M.D. (Chair)     |
| Caley Castelein, M.D. |     | Anupam Dalal, M.D.     |     | Behzad Aghazadeh, Ph.D.        |
| Richard Maroun        |     | Caley Castelein, M.D.  |     | Karin Hehenberger, M.D., Ph.D. |

Audit Committee Caley Castelein, Richard Maroun and Emma Reeve serve on the Audit Committee, which is chaired by Ms. Reeve. Our board of directors has determined that Caley Castelein, M.D., Richard Maroun and Emma Reeve are “independent” for Audit Committee purposes as that term is defined in the rules of the SEC and the applicable Nasdaq rules, and each has sufficient knowledge in financial and auditing matters to serve on the Audit Committee. Our board of directors has designated Emma Reeve as an “audit committee financial expert,” as defined under the applicable rules of the SEC. The Audit Committee’s responsibilities include:

| • |     | appointing, compensating, retaining, evaluating, overseeing, and assessing the independence of our independent 
 registered public accounting firm;                                                                             |

- 155 -

| • |     | pre-approving auditing and permissible                                                                                   
 non-audit services, and the terms of such services, to be provided by our independent registered public accounting firm; |

| • |     | reviewing the overall audit plan with our independent registered public accounting firm and members of management 
 responsible for preparing our financial statements;